Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hua Jin, PhD
University of California, San Diego
Principal Investigator - Jijun Wang, PhD
Shanghai Mental Health Center
Study Director - Tianhong Zhang, PhD
Shanghai Mental Health Center
Principal Investigator - Xiaolong Li, PhD
Shenzhen Fushan Biotech Co., Ltd.
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Guangzhou Psychiatric Hospital
Guangzhou, Guangdong, China
- the First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
- Second Xiangya Hospital of Central South University
Changsha, Hunan, China
- Suzhou Psychiatric Hospital
Suzhou, Jiangsu, China
- Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China
- Shanghai Pudong Nanhui Mental Health Center
Shanghai, Shanghai Municipality, China
- Shanghai Xuhui District Mental Health Center
Shanghai, Shanghai Municipality, China
- Shenzhen Kangning Hospital
Shenzhen, Shenzhen, China
- Tianjin Anding Hospital
Tianjin, Tianjin Municipality, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Jul 2019
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 3 Jun 2026
- Registered enrollment
- 300
- Registry id
- NCT03932136
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.